![Opzelura cream (Ruxolitinib) how to use: How and when to take it, Who can't take Ruxolitinib - YouTube Opzelura cream (Ruxolitinib) how to use: How and when to take it, Who can't take Ruxolitinib - YouTube](https://i.ytimg.com/vi/nVAjIy1T-GI/maxresdefault.jpg)
Opzelura cream (Ruxolitinib) how to use: How and when to take it, Who can't take Ruxolitinib - YouTube
![Incyte Announces U.S. FDA Approval of Opzelura™ (ruxolitinib) Cream for the Treatment of Vitiligo | Incyte Incyte Announces U.S. FDA Approval of Opzelura™ (ruxolitinib) Cream for the Treatment of Vitiligo | Incyte](https://mms.businesswire.com/media/20220718005819/en/1513195/4/VitiligoPatientImage.jpg)
Incyte Announces U.S. FDA Approval of Opzelura™ (ruxolitinib) Cream for the Treatment of Vitiligo | Incyte
![Incyte Announces U.S. FDA Approval of Opzelura™ (ruxolitinib) Cream for the Treatment of Vitiligo | Business Wire Incyte Announces U.S. FDA Approval of Opzelura™ (ruxolitinib) Cream for the Treatment of Vitiligo | Business Wire](https://mms.businesswire.com/media/20220718005819/en/1513185/5/VitiligoAdvocacyVideo_Final.jpg)
Incyte Announces U.S. FDA Approval of Opzelura™ (ruxolitinib) Cream for the Treatment of Vitiligo | Business Wire
![Dos estudios demuestran la eficacia de una crema contra la despigmentación de la piel causada por el vitíligo | Salud Dos estudios demuestran la eficacia de una crema contra la despigmentación de la piel causada por el vitíligo | Salud](https://e00-elmundo.uecdn.es/assets/multimedia/imagenes/2022/10/19/16661996119239.jpg)
Dos estudios demuestran la eficacia de una crema contra la despigmentación de la piel causada por el vitíligo | Salud
![Opzelura cream (Ruxolitinib) how to use: How and when to take it, Who can't take Ruxolitinib - YouTube Opzelura cream (Ruxolitinib) how to use: How and when to take it, Who can't take Ruxolitinib - YouTube](https://i.ytimg.com/vi/nVAjIy1T-GI/hqdefault.jpg)
Opzelura cream (Ruxolitinib) how to use: How and when to take it, Who can't take Ruxolitinib - YouTube
![Incyte Announces U.S. FDA Approval of Opzelura™ (ruxolitinib) Cream for the Treatment of Vitiligo | Business Wire Incyte Announces U.S. FDA Approval of Opzelura™ (ruxolitinib) Cream for the Treatment of Vitiligo | Business Wire](https://mms.businesswire.com/media/20220718005819/en/1513196/5/OpzeluraLogo.jpg)